X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (216) 216
male (164) 164
middle aged (139) 139
female (128) 128
aged (114) 114
surgery (107) 107
index medicus (102) 102
adult (69) 69
oncology (67) 67
liver neoplasms - pathology (57) 57
hepatectomy (53) 53
liver neoplasms - surgery (53) 53
gastroenterology & hepatology (49) 49
carcinoma, hepatocellular - pathology (47) 47
prognosis (46) 46
cancer (45) 45
hepatocellular carcinoma (42) 42
treatment outcome (41) 41
carcinoma, hepatocellular - surgery (39) 39
medicine & public health (38) 38
chemotherapy (36) 36
transplantation (33) 33
liver neoplasms - drug therapy (32) 32
retrospective studies (32) 32
combined modality therapy (29) 29
liver transplantation (29) 29
liver (28) 28
recurrence (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (27) 27
liver cancer (27) 27
carcinoma, hepatocellular - drug therapy (26) 26
fluorouracil - administration & dosage (25) 25
liver neoplasms - therapy (24) 24
aged, 80 and over (23) 23
gemcitabine (23) 23
hepatic resection (23) 23
living donors (23) 23
metastasis (22) 22
survival (22) 22
tomography, x-ray computed (22) 22
analysis (21) 21
care and treatment (21) 21
deoxycytidine - analogs & derivatives (21) 21
pancreatic cancer (21) 21
time factors (21) 21
carcinoma, hepatocellular - therapy (20) 20
health aspects (20) 20
hepatoma (20) 20
neoplasm invasiveness (19) 19
antimetabolites, antineoplastic - therapeutic use (18) 18
gastroenterology (18) 18
interferon-alpha - administration & dosage (18) 18
survival rate (18) 18
therapy (18) 18
cell line, tumor (17) 17
cells (17) 17
drug combinations (17) 17
expression (17) 17
follow-up studies (17) 17
gene expression (17) 17
intraarterial 5-fluorouracil (17) 17
medical prognosis (17) 17
risk factors (17) 17
surgical oncology (17) 17
tumors (17) 17
interferon (16) 16
neoplasm staging (16) 16
pancreatic neoplasms - pathology (16) 16
patients (16) 16
antineoplastic combined chemotherapy protocols - administration & dosage (15) 15
immunohistochemistry (15) 15
liver neoplasms - mortality (15) 15
multivariate analysis (15) 15
prospective studies (15) 15
resection (15) 15
animals (14) 14
articles (14) 14
carcinoma, hepatocellular - mortality (14) 14
disease-free survival (14) 14
japan (14) 14
tegafur - administration & dosage (14) 14
apoptosis (13) 13
cancer therapies (13) 13
carcinoma (13) 13
deoxycytidine - therapeutic use (13) 13
hepatocellular-carcinoma (13) 13
infusions, intra-arterial (13) 13
liver neoplasms - genetics (13) 13
liver neoplasms - secondary (13) 13
management (13) 13
mice (13) 13
pancreatic neoplasms - surgery (13) 13
antimetabolites, antineoplastic - administration & dosage (12) 12
bile duct neoplasms - surgery (12) 12
carcinoma, hepatocellular - genetics (12) 12
cholangiocarcinoma - surgery (12) 12
combination therapy (12) 12
hepatology (12) 12
liver neoplasms - metabolism (12) 12
lymphatic metastasis (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Hepatology, ISSN 0168-8278, 2016, Volume 65, Issue 5, pp. 1061 - 1061
Journal Article
Journal of Hepatology, ISSN 0168-8278, 11/2016, Volume 65, Issue 5, p. 1061
Journal Article
Nature Genetics, ISSN 1061-4036, 05/2016, Volume 48, Issue 5, pp. 500 - 509
Journal Article
by Fujimoto, Akihiro and Fujimoto, Akihiro and Furuta, Mayuko and Furuta, Mayuko and Shiraishi, Yuichi and Shiraishi, Yuichi and Gotoh, Kunihito and Gotoh, Kunihito and Kawakami, Yoshiiku and Kawakami, Yoshiiku and Arihiro, Koji and Arihiro, Koji and Nakamura, Toru and Nakamura, Toru and Ueno, Masaki and Ueno, Masaki and Ariizumi, Shun-Ichi and Ariizumi, Shun-ichi and Nguyen, Ha Hai and Nguyen, Ha H.ai and Shigemizu, Daichi and Shigemizu, Daichi and Abe, Tetsuo and Abe, Tetsuo and Boroevich, Keith A and Boroevich, Keith A and Nakano, Kaoru and Nakano, Kaoru and Sasaki, Aya and Sasaki, Aya and Kitada, Rina and Kitada, Rina and Maejima, Kazihiro and Maejima, Kazihiro and Yamamoto, Yujiro and Yamamoto, Yujiro and Tanaka, Hiroko and Tanaka, Hiroko and Shibuya, Tetsuo and Shibuya, Tetsuo and Shibata, Tatsuhiro and Shibata, Tatsuhiro and Ojima, Hidenori and Ojima, Hidenori and Shimada, Kazuaki and Shimada, Kazuaki and Hayami, Shinya and Hayami, Shinya and Shigekawa, Yoshinobu and Shigekawa, Yoshinobu and Aikata, Hiroshi and Aikata, Hiroshi and Ohdan, Hideki and Ohdan, Hideki and Marubashi, Shigeru and Marubashi, Shigeru and Yamada, Terumasa and Yamada, Terumasa and Kubo, Michiaki and Kubo, Michiaki and Hirano, Satoshi and Hirano, Satoshi and Ishikawa, Osamu and Ishikawa, Osamu and Yamamoto, Masakazu and Yamamoto, Masakazu and Yamaue, Hiroki and Yamaue, Hiroki and Chayama, Kazuaki and Chayama, Kazuaki and Miyano, Satoru and Miyano, Satoru and Tsunoda, Tatsuhiko and Tsunoda, Tatsuhiko and Nakagawa, Hidewaki and Nakagawa, Hidewaki
Nature communications, ISSN 2041-1723, 2015, Volume 6, Issue 1, p. 6120
Journal Article
Cancer Science, ISSN 1347-9032, 09/2015, Volume 106, Issue 9, pp. 1182 - 1187
Journal Article
American Journal of Surgery, The, ISSN 0002-9610, 2011, Volume 202, Issue 2, pp. 214 - 219
Journal Article
Cancer Science, ISSN 1347-9032, 05/2015, Volume 106, Issue 5, pp. 584 - 591
The BRCA/Fanconi anemia (FA) pathway plays a key role in the repair of DNA double strand breaks. We focused on this pathway to clarify chemoresistance... 
RAD51c | Fanconi anemia | BRCA2 | CD24 | FANCD2 | STEM-CELLS | BRCA1 | INTERLEUKIN-6 | CHEMOTHERAPY | BREAST | H2AX PHOSPHORYLATION | RAD51 | POLYMORPHISMS | CISPLATIN | ONCOLOGY | DNA-REPAIR | Fanconi Anemia Complementation Group D2 Protein - genetics | CD24 Antigen - metabolism | Humans | Middle Aged | Glycoproteins - metabolism | Deoxycytidine - pharmacology | Male | Antigens, CD - metabolism | Peptides - metabolism | Biliary Tract Neoplasms - metabolism | Hyaluronan Receptors - metabolism | Antimetabolites, Antineoplastic - pharmacology | Female | Biliary Tract Neoplasms - drug therapy | Gene Expression Regulation, Neoplastic - drug effects | Biliary Tract Neoplasms - genetics | Rad51 Recombinase - metabolism | Rad51 Recombinase - genetics | Cisplatin - pharmacology | AC133 Antigen | BRCA2 Protein - metabolism | Fanconi Anemia Complementation Group D2 Protein - metabolism | Cell Line, Tumor | Aged | RNA, Small Interfering | Metabolic Networks and Pathways - drug effects | BRCA2 Protein - genetics | Deoxycytidine - analogs & derivatives | Drug Resistance, Neoplasm - drug effects | Biliary tract | Flow cytometry | Gemcitabine | Anemia | DNA damage | Genes | Cloning | Chemoresistance | Breast cancer | siRNA | Kinases | Fanconi syndrome | Cancer therapies | DNA repair | Cisplatin | Chemotherapy | Medical prognosis | Cell lines | Stem cells | Cell cycle | Population | Deoxyribonucleic acid--DNA | Original
Journal Article
PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0145985
Journal Article
Journal Article
Liver Transplantation, ISSN 1527-6465, 05/2016, Volume 22, Issue 5, pp. 599 - 606
Small‐for‐size graft syndrome is an inevitable complication in living donor liver transplantation (LDLT). We hypothesized that graft weight (GW) measured after... 
Severity of Illness Index | Multivariate Analysis | Prospective Studies | Humans | Middle Aged | Risk Factors | Postoperative Period | Organ Size | Graft Survival | Liver - anatomy & histology | Male | Tomography, X-Ray Computed | Treatment Outcome | Living Donors | Transplant Recipients | Liver Transplantation - methods | Regression Analysis | Adult | Female | Aged | Liver - surgery | Preoperative Period
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2011, Volume 56, Issue 1, pp. 167 - 175
Journal Article